Cargando…

Therapeutic management of diabetic kidney disease

During the past 10 years, a global pandemic of end‐stage renal disease (ESRD) attributed to diabetes mellitus has changed the therapeutic strategies based on landmark trials that have shown that diabetic micro‐ and macrovascular complications might be preventable. However, the remaining risk of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koya, Daisuke, Araki, Shin‐ichi, Haneda, Masakazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014961/ https://www.ncbi.nlm.nih.gov/pubmed/24843492 http://dx.doi.org/10.1111/j.2040-1124.2011.00112.x

Ejemplares similares

Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014
por: Kume, Shinji, et al.
Publicado: (2019)

Predictive Effects of Urinary Liver-Type Fatty Acid–Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus
por: Sawaguchi, Makoto, et al.
Publicado: (2012)

Hypoxia in Diabetic Kidneys
por: Takiyama, Yumi, et al.
Publicado: (2014)

Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen
por: Nitta, Kyoko, et al.
Publicado: (2016)

The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research
por: Kitada, Munehiro, et al.
Publicado: (2023)

Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Association Between Urinary Type IV Collagen Level and Deterioration of Renal Function in Type 2 Diabetic Patients Without Overt Proteinuria
por: Araki, Shin-ichi, et al.
Publicado: (2010)

Predictive Properties of Plasma Amino Acid Profile for Cardiovascular Disease in Patients with Type 2 Diabetes
por: Kume, Shinji, et al.
Publicado: (2014)

Diabetic kidney disease: Its current trends and future therapeutic perspectives
por: Koya, Daisuke
Publicado: (2019)

Correlation Between Albuminuria and Spontaneous Platelet Microaggregate Formation in Type 2 Diabetic Patients
por: Araki, Shin-ichi, et al.
Publicado: (2009)

Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis
por: Kume, Shinji, et al.
Publicado: (2012)

GW501516, a PPARδ Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NFκB Pathway in Mice
por: Yang, Xu, et al.
Publicado: (2011)

Randomized trial of an intensified, multifactorial intervention in patients with advanced‐stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan)
por: Shikata, Kenichi, et al.
Publicado: (2020)

Impact of empagliflozin on diabetic kidney disease
por: Koya, Daisuke
Publicado: (2017)

Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case report
por: Koya, Daisuke, et al.
Publicado: (2004)

Dual protein kinase C alpha and beta inhibitors and diabetic kidney disease: a revisited therapeutic target for future clinical trials
por: Koya, Daisuke
Publicado: (2013)

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
por: Shi, Sen, et al.
Publicado: (2016)

Autophagy: A Novel Therapeutic Target for Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2015)

NAD(+) Homeostasis in Diabetic Kidney Disease
por: Xu, Jing, et al.
Publicado: (2021)

SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
por: Kitada, Munehiro, et al.
Publicado: (2013)

Combined effect of sodium–glucose cotransporter 2 and dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease
por: Araki, Shin‐ichi
Publicado: (2019)

Mammalian autophagy is essential for hepatic and renal ketogenesis during starvation
por: Takagi, Ayano, et al.
Publicado: (2016)

Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021)

Japanese Clinical Practice Guideline for Diabetes 2016
por: Haneda, Masakazu, et al.
Publicado: (2018)

A Low-Protein Diet for Diabetic Kidney Disease: Its Effect and Molecular Mechanism, an Approach from Animal Studies
por: Kitada, Munehiro, et al.
Publicado: (2018)

Association Between Remission of Macroalbuminuria and Preservation of Renal Function in Patients With Type 2 Diabetes With Overt Proteinuria
por: Yokoyama, Hiroki, et al.
Publicado: (2013)

MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
por: Srivastava, Swayam Prakash, et al.
Publicado: (2013)

New glycemic targets for patients with diabetes from the Japan Diabetes Society
por: Araki, Eiichi, et al.
Publicado: (2016)

Exercise Ameliorates Diabetic Kidney Disease in Type 2 Diabetic Fatty Rats
por: Monno, Itaru, et al.
Publicado: (2021)

Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes
por: Oshima, Megumi, et al.
Publicado: (2021)

Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic β Cells during Fasting and in Type 2 Diabetes
por: Kume, Shinji, et al.
Publicado: (2016)

Autophagy as a Therapeutic Target in Diabetic Nephropathy
por: Tanaka, Yuki, et al.
Publicado: (2012)

Therapeutic Advances in Diabetic Kidney Disease
por: Georgianos, Panagiotis I., et al.
Publicado: (2023)

Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial
por: Uzu, Takashi, et al.
Publicado: (2016)

Clinical Use and Treatment Mechanism of Molecular Hydrogen in the Treatment of Various Kidney Diseases including Diabetic Kidney Disease
por: Hirano, Shin-ichi, et al.
Publicado: (2023)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2013)

Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control
por: Betônico, Carolina C R, et al.
Publicado: (2016)

Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001–2010: Report of the Committee on Causes of Death in Diabetes Mellitus
por: Nakamura, Jiro, et al.
Publicado: (2017)

Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
por: Toth-Manikowski, Stephanie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8ponmaupsoit3shuakl6ts8g66